TOP STORIES

• BUSINESS Jevtana Supply Crunch amid Demand Spike Already Affecting Patients in Japan
  May 7, 2024

• BUSINESS Sumitomo Sets Out for Reconstruction, Further Cost Cuts in FY2024
  May 2, 2024

• BUSINESS Regeneron Set for Commercial Expansion in Japan, Eyes Dupixent Ramp-Up
  May 1, 2024

• BUSINESS Celltrion Japan Unveils New List of 5 Biosimilars in Development; Actemra and Pralia and More
  May 1, 2024

• REGULATORY Japan’s 1st Eylea Biosimilar Now in Line for Approval, AMD Dropped for Patent Reasons
  April 30, 2024

• BUSINESS Janssen Primed to Join Japan Lung Cancer Market with Doublet Now under Review
  April 26, 2024

• REGULATORY Japan Plans More Prompt Drug Approvals from 2025, Within 3 Weeks of Panel Nod
  April 25, 2024

• BUSINESS Rakuten Medical Ratcheting Up Overseas Expansion Drive for Akalux: Japan Chief
  April 25, 2024

• BUSINESS Bayer Poised to Navigate Patent Cliff with Blockbuster Hopefuls for Stroke, Kidney Disease
  April 24, 2024

• REGULATORY Japan Unveils 1,095 Off-Patent Branded Drugs Subject to New Coverage Rule
  April 23, 2024

• REGULATORY MHLW Proposes Simplified Generic Delisting Scheme
  April 22, 2024

• REGULATORY More Unexpected Substances in Kobayashi’s Beni-Koji Supplements: MHLW
  April 22, 2024

• REGULATORY MHLW Panel Sets Topics for PMD Act Amendment; Pediatrics, Drug Loss on Agenda
  April 19, 2024

• ORGANIZATION Doctors’ Lobby Objects MOF Proposal for CEA Use in Reimbursement Decisions
  April 18, 2024

• REGULATORY MOF Ramps Up Push for Use of Cost-Effectiveness Assessment in Reimbursement Decisions
  April 17, 2024

• BUSINESS Moderna to File mRNA RSV Vaccine in Japan within 2024: Exec
  April 17, 2024

• REGULATORY PMDA Stepping Up Generic Compliance Inspections from August Approvals
  April 16, 2024

• BUSINESS 80%-Plus Doctors Seek In-Person Meetings with Reps: Lilly Survey
  April 16, 2024

• REGULATORY Japan Might Approve 1st Eylea Biosimilar by June, but Not AMD Use
  April 15, 2024

• BUSINESS Wholesaler Purchase Prices of Unprofitable Drugs on Upward Trend after FY2024 Revision
  April 12, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• …
• Next ›
• 最終 »